Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Vodafone Group Plc American Depositary Shares (VOD) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance

Vodafone Group Plc American Depositary SharesTrade
State Street SPDR S&P Biotech ETFTrade

Price performance (Past 24H)

Key statistics

Vodafone Group Plc American Depositary Shares vs State Street SPDR S&P Biotech ETF — how do they compare? Vodafone Group Plc American Depositary Shares trades at $15.83 (market cap $39.26B), while State Street SPDR S&P Biotech ETF trades at $149.68 (market cap $10.08B). The key difference: Vodafone Group Plc American Depositary Shares is far larger — about 3.9× State Street SPDR S&P Biotech ETF's market cap, and Vodafone Group Plc American Depositary Shares pays a 3.2% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Vodafone Group Plc American Depositary Shares for 0 Days and State Street SPDR S&P Biotech ETF for 37 Days on average.

VODXBI
Market Cap
$39.26B$10.08B
Volume
4,020,4129,534,635
Sector
MediaBroad Market / Factor
52-Week High
$17.68$169.55
52-Week Low
$11.17$104.99
Typical Hold Time
0 Days37 Days
Enterprise Value
$84.62B—
Dividend Yield
3.2%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Vodafone Group Plc American Depositary Shares

No Aura AI signal available yet.

State Street SPDR S&P Biotech ETF

XBI trades at $150.23, down 0.44% on the day, with bearish technical signals dominating. The ETF faces resistance near $152-154 while finding support at $147-149 levels. Analyst coverage remains limited with a single hold rating, though recent news highlights biotech sector optimism from M&A activity and cancer vaccine breakthroughs. The fund's 0.35% expense ratio compares unfavorably to broader healthcare ETFs but offers targeted biotech exposure.

Outlook remains mixed with technical weakness offset by sector catalysts. The biotech focus provides growth potential but carries higher volatility than diversified healthcare alternatives. Key risks include sector-specific regulatory pressures and the fund's expense structure, while opportunities exist from ongoing pharmaceutical innovation and capital market improvements.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

VOD
100% Buy0% Sell
Avg holding period · 0 Days
XBI
100% Buy0% Sell
Avg holding period · 37 Days

About Vodafone Group Plc American Depositary Shares

Vodafone provides mobile, fixed-line, broadband, and business communications services. It operates across Europe and Africa.

Read more on VOD →

About State Street SPDR S&P Biotech ETF

XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.

Read more on XBI →